Amorolfine
As of the edition of 20 October 2026, Amorolfine is a small molecule: marketed, first approved in 1991 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1995
- Kind
- Small molecule
- Brand name
- Loceryl
- First approved
- 18 December 1991 (CH)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Laboratorios Galderma S.A.; 3 holders in all
- Registered trials
- 3, 0 stopped early
- Disease areas
- Infections; Skin and connective tissue
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 0 | 1 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 3 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Galderma | Applicant | 1991 to now |